The Cytonet Group is an international biotechnology company with locations in Weinheim and Heidelberg, Germany and in Durham, North Carolina in the U.S. The company develops and produces cell therapeutic products, including human liver cells. Cytonet’s goal is to provide alternatives to existing therapies for many diseases with a particular emphasis on liver diseases. Cytonet is a pioneer and leader in the field of regenerative medicine. Through the development of novel approaches to treatment we are helping to shape the future of medicine.